Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Patients Receiving Inotuzumab Ozogamicin Followed By Total Body Irradiation-Based Conditioning for Stem Cell Transplantation: A Risk Mitigation Strategy

Ahmed Alahmadi, Abdulrahman Nasiri, Sarah Samarkandi, Haya Alothaimeen, Marwa Nassar, Ali Alahmari, Ahmad S. Alotaibi, Mansour Alfayez, Hanan Alkhaldi, Ayman Saad, Syed Osman Ahmed, Amr Hanbali

Blood (2024) 144 (Supplement 1): 7306.

https://doi.org/10.1182/blood-2024-200803

Published: 2024

Journal Articles

Steroid Pre-Busulfan Based Reduced-Intensity Conditioning in Matched Related Hematopoietic Stem Cell Transplantation: Outcomes in Young and Adult Sickle Cell Disease Patients

Blood (2024) 144 (Supplement 1): 1142.

https://doi.org/10.1182/blood-2024-200303

Published: 2024

Journal Articles

Saudi Acute Myeloid Leukaemia (AML) Genome Reveals Significant Differences from That in the Western Population

Blood (2024) 144 (Supplement 1): 4231.

https://doi.org/10.1182/blood-2024-205025

Published: 2024

Journal Articles

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

Blood (2024) 144 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2024-207937

Published: 2024

Journal Articles

First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families

Alfadil Haroon, Abdullah Aljefri, Mohamed Jaradi, Ahmad S. Alotaibi, Mansour Alfayez, Hazza Alzahrani, Fahad Almohareb, Ali D Alahmari, Ayman Saad, Walid Rasheed, Fahad Z. Alsharif, Naeem A. Chaudhri, Haitham A. Khogeer, Abdullah Alsuwaidan, Mahmoud Aljurf, Syed Osman Ahmed

Blood (2024) 144 (Supplement 1): 5706.

https://doi.org/10.1182/blood-2024-193282

Published: 2024

Journal Articles

Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 7153.

https://doi.org/10.1182/blood-2024-207988

Published: 2024

Journal Articles

Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

Blood (2024) 144 (Supplement 1): 7824.

https://doi.org/10.1182/blood-2024-203769

Published: 2024

Journal Articles

Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

Blood (2024) 144 (Supplement 1): 7754.

https://doi.org/10.1182/blood-2024-202399

Published: 2024

Journal Articles

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Reem Alasbali, Mohsen Alzahrani, Saud Alhayli, Walid Rasheed, Phavina Akhom, Karina Wilkerson, Mohammed Essa, Riad Elfakih, Bader Alahmari, Hadeel Samarkandi, Syed Osman Ahmed, Ayman Saad, Hazza A. Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Adetola A. Kassim, Ali D Alahmari

Blood (2023) 142 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2023-189914

Published: 2023

Journal Articles

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Blood (2023) 142 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2023-182333

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blood (2023) 142 (Supplement 1): 7101.

https://doi.org/10.1182/blood-2023-185676

Published: 2023

Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Blood (2023) 142 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2023-187940

Published: 2023

Journal Articles

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience

Reem Alasbali, Abdulrahman Nasiri, Alfadil Adam, Saud Alhayli, Naeem A. Chaudhri, Alfadel Alshaibani, Abdulwahab Albabtain, Hadeel Samarkandi, Ayman Saad, Abdullah Alamer, Tusneem Ahmed M Elhassan, Hazza A. Alzahrani, Syed Osman Ahmed, Walid Rasheed, Riad Elfakih, Mahmoud Aljurf, ALI D Alahmari

Blood (2023) 142 (Supplement 1): 6936.

https://doi.org/10.1182/blood-2023-182580

Published: 2023

Journal Articles

Comparable Outcomes of Relapsed Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYA) Patients Treated with Pediatric-Inspired Chemotherapy (R3 protocol) Versus Adult-Based Salvage (FA) Protocol

Chokri Ben Lamine, Mohammed Alshehri, Lara Samhan, Maha Abdullah Hassan, Tusneem Ahmed M Elhassan, Riad Elfakih, Feras Abdulaziz Alfraih, Syed Osman Ahmed, Amr Hanbali

Blood (2023) 142 (Supplement 1): 5903.

https://doi.org/10.1182/blood-2023-172868

Published: 2023

Journal Articles

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Blood (2018) 132 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2018-99-114639

Published: 2018

Journal Articles

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Reem Alharbi, Mahmoud Aljurf, MD, Raid El Fakih, MD, Mohammad Al Nahedh, PharmD, Majed Huessein, MD, Zubeir Ahmed Nurgat, BSc, MSc, Almohareb Fahad, MD, Naeem A. Chaudhri, MD, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Saud Alhayli, MD, Riad Youniss, Shahrukh Hashmi, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 3358.

https://doi.org/10.1182/blood-2018-99-114667

Published: 2018

Journal Articles

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Ayodele Alaiya, MPH, MBBS, PhD, Mahmoud Aljurf, MD, Zakia Shinwari, MSc, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP, Tarek Owaidah, MD FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Riad Elfakih, MD, Saud Alhayli, MD, Shahrukh Hashmi, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD

Blood (2018) 132 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2018-99-118754

Published: 2018

Journal Articles

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

Blood (2016) 128 (22): 5871.

https://doi.org/10.1182/blood.V128.22.5871.5871

Published: 2016

Journal Articles

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Feras Alfraih, MD, Amjad Alhussaini, Farhan Anjum, Ghuzayel Mubarak Aldawsari, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Syed Osman Ahmed, MRCP, FRCPath, Amr Hanbali, MD, Marwan Shaheen, MD, Riad O. El Fakih, MD, Hazza A Alzahrani, MD, Naeem A. Chaudhri, MD FACP, Fahad Almohareb, Mahmoud Aljurf, MD MPH

Blood (2016) 128 (22): 5759.

https://doi.org/10.1182/blood.V128.22.5759.5759

Published: 2016

Journal Articles

Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia

Blood (2016) 128 (22): 4624.

https://doi.org/10.1182/blood.V128.22.4624.4624

Published: 2016

NARROW

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Patients Receiving Inotuzumab Ozogamicin Followed By Total Body Irradiation-Based Conditioning for Stem Cell Transplantation: A Risk Mitigation Strategy

Steroid Pre-Busulfan Based Reduced-Intensity Conditioning in Matched Related Hematopoietic Stem Cell Transplantation: Outcomes in Young and Adult Sickle Cell Disease Patients

Saudi Acute Myeloid Leukaemia (AML) Genome Reveals Significant Differences from That in the Western Population

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families

Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia

Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience

Comparable Outcomes of Relapsed Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYA) Patients Treated with Pediatric-Inspired Chemotherapy (R3 protocol) Versus Adult-Based Salvage (FA) Protocol

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Efficacy and Feasibility of Sorafenib As a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only